Jolien Rietkerk
@jolienrietkerk.bsky.social
Postdoctoral Researcher in Cross-Population Psychiatric Genetics at the POP-GEM lab with Dr. Roseann Peterson and Prof. Dr. Hanna van Loo
I did it! 🎓 Defended my doctoral dissertation at TUM with magna cum laude distinction. For supporting me during 4+ years of hard work and setbacks, I’m grateful to my supervisors, collaborators, family & friends for their support on this amazing journey. Thank you all!
November 17, 2025 at 11:19 AM
I did it! 🎓 Defended my doctoral dissertation at TUM with magna cum laude distinction. For supporting me during 4+ years of hard work and setbacks, I’m grateful to my supervisors, collaborators, family & friends for their support on this amazing journey. Thank you all!
Missing colleagues and collaborators already, but feeling inspired after WCPG 2025! Thanks to everyone for making it such an amazing experience.
Curious about the experience? Check out my blogpost! rietkerk-research.com/diversity-di...
Curious about the experience? Check out my blogpost! rietkerk-research.com/diversity-di...
October 31, 2025 at 10:32 AM
Missing colleagues and collaborators already, but feeling inspired after WCPG 2025! Thanks to everyone for making it such an amazing experience.
Curious about the experience? Check out my blogpost! rietkerk-research.com/diversity-di...
Curious about the experience? Check out my blogpost! rietkerk-research.com/diversity-di...
Good morning #WCPG2025 @ispg.bsky.social! I'm so excited to talk about my latest work performing inclusive QC in Lifelines! Come find me at M89 later today! This is the first fruit of my work with Dr. @roseannpeterson.bsky.social, the @popgemlab.bsky.social and Prof. Dr. Hanna van Loo.
October 20, 2025 at 2:14 PM
Good morning #WCPG2025 @ispg.bsky.social! I'm so excited to talk about my latest work performing inclusive QC in Lifelines! Come find me at M89 later today! This is the first fruit of my work with Dr. @roseannpeterson.bsky.social, the @popgemlab.bsky.social and Prof. Dr. Hanna van Loo.
At @ecnp.eu they know what impact is! Had a very inspiring time at the conference, thanks again to the organization for inviting me. I'm taking many ideas and new connections with me into my research ✨
October 14, 2025 at 2:35 PM
At @ecnp.eu they know what impact is! Had a very inspiring time at the conference, thanks again to the organization for inviting me. I'm taking many ideas and new connections with me into my research ✨
Good morning @ecnp.eu!
Will I see you at the auditorium in half an hour (11:20)? I'm speaking in the depression heterogeneity symposium, come say hi!
Will I see you at the auditorium in half an hour (11:20)? I'm speaking in the depression heterogeneity symposium, come say hi!
October 12, 2025 at 8:55 AM
Good morning @ecnp.eu!
Will I see you at the auditorium in half an hour (11:20)? I'm speaking in the depression heterogeneity symposium, come say hi!
Will I see you at the auditorium in half an hour (11:20)? I'm speaking in the depression heterogeneity symposium, come say hi!
I've been honored with an invitation to speak at #ECNP2025, looking forward to talk about our latest pre-print during the S04 symposium session on depression heterogeneity!
Preprint: www.medrxiv.org/content/10.1...
More info on my website: www.rietkerk-research.com
Preprint: www.medrxiv.org/content/10.1...
More info on my website: www.rietkerk-research.com
Genetic risk effects on psychiatric disorders act in sets
Genetic studies of psychiatric disorders have typically assumed that all genetic effects contribute additively to disease liability. However, it is likely that psychiatric disorders have unrecognized ...
www.medrxiv.org
September 16, 2025 at 7:15 AM
I've been honored with an invitation to speak at #ECNP2025, looking forward to talk about our latest pre-print during the S04 symposium session on depression heterogeneity!
Preprint: www.medrxiv.org/content/10.1...
More info on my website: www.rietkerk-research.com
Preprint: www.medrxiv.org/content/10.1...
More info on my website: www.rietkerk-research.com
Reposted by Jolien Rietkerk
Very happy to share our new paper now on @medrxivpreprint: “Genetic risk effects on psychiatric disorders act in sets”, a great effort led my PhD student @jolienrietkerk.bsky.social, and performed together with collaborators Andy Dahl, Jonathan Flint, Andrew Schork etc. Thread 1/n
July 24, 2025 at 5:24 AM
Very happy to share our new paper now on @medrxivpreprint: “Genetic risk effects on psychiatric disorders act in sets”, a great effort led my PhD student @jolienrietkerk.bsky.social, and performed together with collaborators Andy Dahl, Jonathan Flint, Andrew Schork etc. Thread 1/n
‘Genetic Risk Effects on Psychiatric Disorders Act in Sets’, the title of our new preprint on
@medrxivpreprint.bsky.social! This huge collaborative effort advances our understanding of psychiatric genetic architecture and emphasizes the importance of looking beyond additive effects. 🧵1/n; 🧪👩🏽🔬🧬
@medrxivpreprint.bsky.social! This huge collaborative effort advances our understanding of psychiatric genetic architecture and emphasizes the importance of looking beyond additive effects. 🧵1/n; 🧪👩🏽🔬🧬
July 24, 2025 at 8:16 AM
‘Genetic Risk Effects on Psychiatric Disorders Act in Sets’, the title of our new preprint on
@medrxivpreprint.bsky.social! This huge collaborative effort advances our understanding of psychiatric genetic architecture and emphasizes the importance of looking beyond additive effects. 🧵1/n; 🧪👩🏽🔬🧬
@medrxivpreprint.bsky.social! This huge collaborative effort advances our understanding of psychiatric genetic architecture and emphasizes the importance of looking beyond additive effects. 🧵1/n; 🧪👩🏽🔬🧬
Reposted by Jolien Rietkerk
Last work tweet of 2024 (maybe 😉): I, Ken Kendler, Brad Verhulst, @jorsmo.bsky.social and @andrewgrotzinger.bsky.social et al in the Psychiatric Genomics Consortium Cross Disorder Group (PGC-CDG) wrote a review on challenges studying cross disorder (psych) genetics: www.nature.com/articles/s41...
Assessment and ascertainment in psychiatric molecular genetics: challenges and opportunities for cross-disorder research - Molecular Psychiatry
Molecular Psychiatry - Assessment and ascertainment in psychiatric molecular genetics: challenges and opportunities for cross-disorder research
www.nature.com
December 27, 2024 at 4:28 PM
Last work tweet of 2024 (maybe 😉): I, Ken Kendler, Brad Verhulst, @jorsmo.bsky.social and @andrewgrotzinger.bsky.social et al in the Psychiatric Genomics Consortium Cross Disorder Group (PGC-CDG) wrote a review on challenges studying cross disorder (psych) genetics: www.nature.com/articles/s41...